• Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; 1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
  
• Mutation; HGNC; 1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; 11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
  

PubMed=9637769; DOI=10.1006/excr.1998.4029
Sung V., Gilles C., Murray A., Clarke R., Aaron A.D., Azumi N., Thompson E.W.
The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
Exp. Cell Res. 241:273-284(1998)

PubMed=10432004; DOI=10.1023/A:1006598422203
Thompson E.W., Sung V., Lavigne M.C., Baumann K.H., Azumi N., Aaron A.D., Clarke R.
LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.
Clin. Exp. Metastasis 17:193-204(1999)

PubMed=15679051; DOI=10.1007/s10585-004-4117-z
Thompson E.W., Waltham M.C., Ramus S.J., Hutchins A.-M., Armes J.E., Campbell I.G., Williams E.D., Thompson P.R., Rae J.M., Johnson M.D., Clarke R.
LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.
Clin. Exp. Metastasis 21:535-541(2004)

PubMed=20143388; DOI=10.1002/ijc.25242
Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A., MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R., Freshney R.I.
Check your cultures! A list of cross-contaminated or misidentified cell lines.
Int. J. Cancer 127:1-8(2010)